Insider · CIK 0001896056
Shay Shemesh
Files at NVCT (Nuvectis Pharma, Inc.). First filing -, latest -.
In brief
Shay Shemesh files SEC Form 4 as officer at NVCT (Nuvectis Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Shay Shemesh has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 1,793,068 | Jan 9, 2026 |
| Jan 3, 2024 | NVCT Nuvectis Pharma, Inc. | AGrant or award Common Stock | +130,000 | $0.00 | $0 | 1,491,955 | Jan 5, 2024 |
Questions about Shay Shemesh
Answered from the filings on this page, as of the latest one.
Is Shay Shemesh buying or selling?
Shay Shemesh has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Shay Shemesh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shay Shemesh has 0.
Where does Shay Shemesh file Form 4?
Shay Shemesh has filed Form 4 at NVCT (Nuvectis Pharma, Inc.) as Chief Dev. & Ops. Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.